A Phase 1 Study Of Hmpl-306, A Dual Inhibitor Of Mutant Isocitrate Dehydrogenase (Idh) 1 And 2, In Pts With Relapsed/Refractory Myeloid Hematological Malignancies Harboring Idh1 And/Or 2 Mutations
Hmpl-306
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1 Study Of Hmpl-306, A Dual Inhibitor Of Mutant Isocitrate Dehydrogenase (Idh) 1 And 2, In Pts With Relapsed/Refractory Myeloid Hematological Malignancies Harboring Idh1 And/Or 2 Mutations ### Output: Hmpl-306